Literature DB >> 26484638

Importance of post-translational modifications on the function of key haemostatic proteins.

Vasiliki Karlaftis1, Sachin Perera, Paul Monagle, Vera Ignjatovic.   

Abstract

Post-translational modifications (PTMs) such as glycosylation and phosphorylation play an important role on the function of haemostatic proteins and are critical in the setting of disease. Such secondary level changes to haemostatic proteins have wide ranging effects on their ability to interact with other proteins. This review aimed to summarize the knowledge of the common PTMs associated with haemostatic proteins and the implications of such modifications on protein function. Haemostatic proteins that represent the main focus for studies specific to PTMs are von Willebrand factor, tissue factor, factor VIII, antithrombin and fibrinogen. These proteins are susceptible to PTMs by glycosylation, phosphorylation, sulphation, citrullination and nitration, respectively, with a significant impact on their function. During synthesis, vWF must undergo extensive PTMs, with N-linked glycosylation being the most common. Increased phosphorylation of tissue factor results in increased affinity for platelets to the vessel endothelium. Citrullination of antithrombin leads to an increased anticoagulant function of this protein and therefore an anticoagulant state that inhibits clot formation. On the contrary, nitration of fibrinogen has been shown to result in a prothrombotic state, whilst sulphation is required for the normal function of Factor VIII. From this review, it is evident that PTMs of haemostatic proteins as a change in protein structure at a secondary level greatly influences the behaviour of the protein at a tertiary level.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26484638     DOI: 10.1097/MBC.0000000000000301

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  7 in total

1.  An Insight into Glyco-Microheterogeneity of Plasma von Willebrand Factor by Mass Spectrometry.

Authors:  Ebtesam A Gashash; Arya Aloor; Dong Li; He Zhu; Xiao-Qian Xu; Cong Xiao; Junping Zhang; Aishwarya Parameswaran; Jing Song; Cheng Ma; Weidong Xiao; Peng George Wang
Journal:  J Proteome Res       Date:  2017-07-27       Impact factor: 4.466

2.  Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity.

Authors:  David Pereyra; Florian Offensperger; Florian Klinglmueller; Stefanie Haegele; Lukas Oehlberger; Thomas Gruenberger; Christine Brostjan; Patrick Starlinger
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

3.  Evaluation on blood coagulation and C-reactive protein level among children with mycoplasma pneumoniae pneumonia by different chest imaging findings.

Authors:  Juan Wang; Jianping Mao; Gang Chen; Yuanmei Huang; Jinjin Zhou; Changlong Gao; Danting Jin; Chenying Zhang; Juan Wen; Jun Sun
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

Review 4.  VWF, Platelets and the Antiphospholipid Syndrome.

Authors:  Shengshi Huang; Marisa Ninivaggi; Walid Chayoua; Bas de Laat
Journal:  Int J Mol Sci       Date:  2021-04-18       Impact factor: 5.923

5.  Plasma proteomics reveals coagulation, inflammation, and metabolic shifts in H-type hypertension patients with and without acute ischemic stroke.

Authors:  Feng Zhou; Lv Zhou; Tie Guo; Nianzhen Wang; Haizhen Hao; Yanhui Zhou; Dan Yu
Journal:  Oncotarget       Date:  2017-11-01

6.  Impairment of AMPK-α2 augments detrusor contractions in bladder ischemia.

Authors:  Jing-Hua Yang; Wanting Niu; Yedan Li; Kazem M Azadzoi
Journal:  Investig Clin Urol       Date:  2021-07-19

7.  Common VWF sequence variants associated with higher VWF and FVIII are less frequent in subjects diagnosed with type 1 VWD.

Authors:  Veronica H Flood; Jill M Johnsen; Caroline Kochelek; Tricia L Slobodianuk; Pamela A Christopherson; Sandra L Haberichter; Rupa Udani; Daniel B Bellissimo; Kenneth D Friedman; Robert R Montgomery
Journal:  Res Pract Thromb Haemost       Date:  2018-01-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.